Skip to main content

Table 2 The associations between preoperative CRP, CYFRA 21-1, and clinicopathologic parameters (N = 130)

From: Serum markers of CYFRA 21-1 and C-reactive proteins in oral squamous cell carcinoma

 

CRP

CYFRA 21-1

 

Negative (n (%))

Positive (n (%))

P value

Negative (n (%))

Positive (n (%))

P value

Pathologic tumor status

 Earlya (n = 74)

64 (86.5)

10 (13.5)

<0.001 e

66 (89.2)

8 (10.8)

0.308

 Advancedb (n = 56)

29 (51.8)

27 (48.2)

 

46 (82.1)

10 (17.9)

 

Pathologic N stage

 N0 (n = 68)

54 (79.4)

14 (20.6)

0.049

59 (86.8)

9 (13.2)

0.024

 N1 (n = 25)

18 (72.0)

7 (28.0)

 

25 (100.0)

0 (0.0)

 

 N2 (n = 37)

21 (56.8)

16 (43.2)

 

28 (75.7)

9 (24.3)

 

Nodal status

 (−) metastasis, (−) ECS (n = 68)

54 (79.4)

14 (20.6)

0.014

59 (86.8)

9 (13.2)

0.039

 (+) metastasis, (−) ECS (n = 23)

18 (78.3)

5 (21.7)

 

23 (100.0)

0 (0.0)

 

 (+) metastasis, (+) ECS (n = 39)

21 (53.8)

18 (46.2)

 

30 (76.9)

9 (23.1)

 

Differentiation

 Well (n = 32)

21 (65.6)

11 (34.4)

0.304

29 (90.6)

3 (9.4)

0.689

 Moderate (n = 80)

61 (76.2)

19 (23.8)

 

68 (85.0)

12 (15.0)

 

 Poor (n = 18)

11 (61.1)

7 (38.9)

 

15 (83.3)

3 (16.7)

 

Tumor stage

 Earlyc (n = 45)

40 (88.9)

5 (11.1)

0.002 e

38 (84.4)

7 (15.6)

0.791e

 Advancedd (n = 85)

53 (62.4)

32 (37.6)

 

74 (87.1)

11 (12.9)

 

Skin invasion

 No (n = 117)

88 (75.2)

29 (24.8)

0.009 e

102 (87.2)

15 (12.8)

0.389e

 Yes (n = 13)

5 (38.5)

8 (61.5)

 

10 (76.9)

3 (23.1)

 

Bone invasion

 No (n = 105)

83 (79.0)

22 (21.0)

<0.001 e

91 (86.7)

14 (13.3)

0.750e

 Yes (n = 25)

10 (40.0)

15 (60.0)

 

21 (84.0)

4 (16.0)

 

Tumor depth ≥10 mm

 No (n = 60)

53 (88.3)

7 (11.7)

<0.001 e

54 (90.0)

6 (10.0)

0.311e

 Yes (n = 70)

40 (57.1)

30 (42.9)

 

58 (82.9)

12 (17.1)

 
  1. ECS extracapsular spread
  2. aT1–T2
  3. bT3–T4
  4. cStage I–II
  5. dStage III–IV
  6. eFisher’s exact test